首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

2050789

獸醫腫瘤市場：依動物種類、治療方法、給藥途徑、應用、通路及地區分類

Veterinary Oncology Market, By Animal Type, By Therapy Type, By Mode of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，獸醫腫瘤市場規模將達到 9.078 億美元，到 2033 年將達到 20.068 億美元。預計從 2026 年到 2033 年，該市場將以 12.0% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	9.078億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	12.00%	2033年市場規模預測：	20.068億美元

由於動物醫療保健成本不斷上漲以及寵物數量持續成長，獸醫腫瘤市場正經歷顯著成長。人類與動物之間日益加深的情感聯繫，以及人們對伴侶動物癌症認知的不斷提高，推動了獸醫腫瘤領域對先進診斷和治療方法的需求。此外，犬貓淋巴瘤、乳房腫瘤、口腔黑色素瘤和肥大細胞瘤等癌症發生率的上升，凸顯了有效治療方法方案和早期檢測的必要性。獸醫腫瘤學家和腫瘤專家數量的增加，以及對創新藥物研發的持續投入，進一步推動了全球市場的擴張。然而，癌症治療和診斷的高昂費用仍然是一個巨大的挑戰。

市場動態

全球獸醫腫瘤市場的成長主要受伴侶動物癌症發生率上升、寵物保險投保人數增加、動物醫療保健支出成長以及技術進步的推動。統計顯示，超過50%的10歲以上犬隻患有癌症，其中淋巴瘤是犬隻最常見的血液癌症。快速的都市化，加上核心家庭的興起和孤獨感的加劇，正在推動全球寵物飼養率的上升。這使得寵物飼主更加關注寵物的健康，並越來越願意為更高品質的治療買單。眾多機構為獸醫腫瘤相關的臨床試驗和研究活動提供資金支持，這在市場成長中發揮重要作用。然而，抗癌藥物、診斷測試和手術的高昂費用，以及開發中國家較低的認知水平，預計將在預測期內阻礙市場擴張。透過社群媒體宣傳活動和會議等方式持續提高大眾對寵物癌症的認知，預計將為市場主要參與者帶來許多盈利的機會。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球獸醫腫瘤市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
本研究涵蓋的主要公司包括 Zoetis Inc.、Elanco、AB Science、Boehringer Ingelheim International GmbH、Zenoaq、VetDC、Morphogenesis, Inc.、Karyopharm Therapeutics, Inc.、Regeneus Ltd.、AdvaVet, Inc.、Rhizen Pharmaceutical SA.、PetCure Onccxing、Vonoff創造
本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球獸醫腫瘤市場涵蓋了該行業內各種各樣的相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球獸醫腫瘤市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第10章競爭格局

公司簡介
- Zoetis Inc.
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- Merck Animal Health
- Regeneus Ltd.
- VolitionRx Limited

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI2995

Veterinary Oncology Market is estimated to be valued at USD 907.8 Mn in 2026 and is expected to reach USD 2,006.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 907.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.00%	2033 Value Projection:	USD 2,006.8 Mn

The veterinary oncology market is experiencing significant growth due to rising animal healthcare expenditure and increasing pet ownership. Growing human-animal bonds and rising awareness about cancer in companion animals are propelling demand for advanced diagnostic methods and therapeutic procedures for veterinary oncology. Moreover, increasing incidence of cancers such as lymphoma, mammary tumor, oral melanoma, and mast cell tumors in dogs and cats is driving the need for effective treatment options and early detection. Growing number of veterinary oncologists and oncology specialists along with ongoing research for developing innovative drug formulations are further supporting market expansion on a global level. However, high costs associated with cancer therapies and diagnostic procedures remain a major challenge.

Market Dynamics

The global veterinary oncology market growth is driven by rising incidence of cancer in companion animals, increase in pet insurance purchases, growing animal health expenditure, and technological advancements. According to statistics, over 50% of dogs over the age of 10 will develop cancer and lymphoma is the most common blood cancer in dogs. Rapid urbanization accompanied with rising nuclear families and increasing loneliness levels have boosted pet adoption rates globally. This has led to pet owners becoming more aware regarding the health of their pets and willing to spend more on premium treatments. Various organizations are financially supporting clinical trials and research activities related to veterinary oncology which is playing a significant role in market growth. However, high costs associated with oncology medications, diagnostic tests, surgeries, and lack of awareness in developing nations are anticipated to hamper the market expansion during the forecast period. Ongoing initiatives to spread awareness regarding cancer in pets through social media campaigns and conferences are expected to bring numerous lucrative opportunities for key players in the market.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global veterinary oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, One Health, and Regeneus Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global veterinary oncology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market.

Market Segmentation

By Animal Type (Revenue, USD Mn, 2021 - 2033)
Companion Animal
- Equine
- Canine
- Feline
Livestock Animal
By Therapy Type (Revenue, USD Mn, 2021 - 2033)
Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy
By Mode of Administration (Revenue, USD Mn, 2021 - 2033)
Oral
Intravenous
By Application (Revenue, USD Mn, 2021 - 2033)
Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Others
By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Government Agencies
Retail Pharmacies
By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Zoetis Inc.
Elanco
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
VetDC
Morphogenesis, Inc.
Karyopharm Therapeutics, Inc.
Regeneus Ltd.
AdvaVet, Inc.
Rhizen Pharmaceutical SA.
PetCure Oncology
Varian Medical Systems
Accuray Incorporated
Merck Animal Health
VolitionRx Limited
Regeneus Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Animal Type
- Market Snapshot, By Therapy Type
- Market Snapshot, By Mode of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Epidemiology
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Veterinary Oncology Market, By Animal Type, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Companion Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Equine
  - Canine
  - Feline
Livestock Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Veterinary Oncology Market, By Therapy Type, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Combination Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Targeted Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Veterinary Oncology Market, By Mode of Administration, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Veterinary Oncology Market, By Application, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Canine Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Osteosarcoma (OSA)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Mast Cell Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Melanoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Veterinary Oncology Market, By Distribution Channel, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Government Agencies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Veterinary Oncology Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Zoetis Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elanco
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AB Science
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zenoaq
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- VetDC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Morphogenesis, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Karyopharm Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Regeneus Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AdvaVet, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Rhizen Pharmaceutical SA.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PetCure Oncology
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Varian Medical Systems
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Accuray Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck Animal Health
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Regeneus Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- VolitionRx Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies